A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1997
12/09/1997	US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation
12/09/1997	US5696090 Pharmaceutical composition
12/09/1997	US5696089 Histidine substituted growth hormone releasing factor analogs
12/09/1997	US5696088 Chimeric proteins
12/09/1997	US5696087 Administering a polypeptide
12/09/1997	US5696086 Administering before or after chemotherapy to promote thrombocyte production, also kits
12/09/1997	US5696084 Amino-lipopetide antifungal agents
12/09/1997	US5696083 Personal care composition containing pyrithione and polymyxin
12/09/1997	US5696082 Inhibitors of matrix metalloproteinases and of the production of tumor necrosis factor
12/09/1997	US5696081 A glycoprotein isolated from ultraviolet irradiated epidermal cells culture as immunosuppressants
12/09/1997	US5696080 Pharmaceutical compositions comprising neurotrophic peptides derived from prosaposin
12/09/1997	US5696079 Utilizing a series of administeration to the patient to activate immune system by increasing cd4 protein count in the patient
12/09/1997	US5696078 Fungicides
12/09/1997	US5696077 Pharmaceutical composition containing botulinum B complex
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5696000 Adhesion receptors for pathogenic or opportunistic microorganisms
12/09/1997	US5695997 For altering cell attachment activity of cells
12/09/1997	US5695995 Neurogenic differentiation (neurod) genes
12/09/1997	US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997	US5695993 Cloning and regulation of an endothelial cell protein C/activated protein C receptor
12/09/1997	US5695980 Inserting the specific isolated polynucleotide into a vector to form a recombiant vector
12/09/1997	US5695964 Recombinant DNA vectors, including plasmids, and host cells for production of truncated thrombomodulin
12/09/1997	US5695963 Endothelial PAS domain protein
12/09/1997	US5695959 Recombinant expression of insecticidally effective spider toxin
12/09/1997	US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/09/1997	US5695954 DNA encoding two fish neuropeptides
12/09/1997	US5695953 DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production
12/09/1997	US5695952 Method for producing Leu13 !motilin
12/09/1997	US5695950 Method of screening for antimitotic compounds using the cdc25 tyrosine phosphatase
12/09/1997	US5695938 Genetic engineering
12/09/1997	US5695935 Combining dna from sample with nucleotide probes complementary to the dna sequence of daz gene; detecting hybridization; absence of hybridization indicates reduced sperm count
12/09/1997	US5695932 Telomerase activity assays for diagnosing pathogenic infections
12/09/1997	US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997	US5695927 Preventing the binding of viral glycoprotein to lymphocyte cd4 protein by immobilizing with human immunoglobulins
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695761 Administering a pentapeptide antiinflammatory agent
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
12/09/1997	US5695758 Hybridoma cells
12/09/1997	US5695757 Methods for treating post-exposure rabies and anti-rabies compositions
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/09/1997	US5695754 Staphylokinase derivatives
12/09/1997	US5695753 Transglutaminases as immunosuppressants
12/09/1997	US5695752 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
12/09/1997	US5695751 Administering l-amino acid oxidase to reduce plasma level of large amino acids to allow increased transport of large amino acid drugs across blood brain barrier
12/09/1997	CA2135922C Quick-change tool holder with center-height adjustment mechanism
12/09/1997	CA2058935C Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
12/04/1997	WO1997045746A2 Prion protein binding proteins and uses thereof
12/04/1997	WO1997045744A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
12/04/1997	WO1997045558A1 Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections
12/04/1997	WO1997045550A2 Mini-adenoviral vector
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045543A2 Cc chemokine receptor 5, antibodies thereto, transgenic animals
12/04/1997	WO1997045542A2 Cell growth regulatory genes
12/04/1997	WO1997045540A1 Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis
12/04/1997	WO1997045538A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
12/04/1997	WO1997045536A1 Acylcoenzyme a:cholesterol acyltransferase-related enzymes in yeast and uses thereof
12/04/1997	WO1997045531A1 Gonadotrophin releasor hormone-containing composition and method for treating infertility
12/04/1997	WO1997045528A2 Mammalian tolloid-like gene and protein
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045448A1 An interleukin-5 antagonist
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045446A1 Glycine transporter-transfected cells and uses thereof
12/04/1997	WO1997045439A1 Dna encoding acylcoenzyme a: cholesterol acyltransferase and uses thereof
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045412A1 A method of treating cancer
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045144A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	WO1997045140A1 Concentrated antibody preparation
12/04/1997	WO1997045139A2 Il-12 as an adjuvant for bordetella pertussis vaccines
12/04/1997	WO1997045138A1 New improved formulation for treatment of thromboembolism
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045136A1 Lactoferrin variants and uses thereof
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045127A1 Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
12/04/1997	WO1997045117A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/04/1997	WO1997045107A1 Remedies for brain diseases
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997045015A1 Modulation of opioid receptor-mediated macrophage chemotactic activity
12/04/1997	WO1997045000A1 Metal-regulated transporters and uses therefor
12/04/1997	WO1997041206A3 Von willebrand factor multimerase
12/04/1997	WO1997041150A3 Gene therapy for mitochondrial dna deffects using peptide nucleic acids
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997038689A3 Enteric-coated pharmaceutical compositions of mycophenolate
12/04/1997	WO1997038293A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto
12/04/1997	WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997	CA2257148A1 Mini-adenoviral vector
12/04/1997	CA2256669A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256577A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	CA2256498A1 Cell growth regulatory genes
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256453A1 Lactoferrin variants and uses thereof
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256368A1 An interleukin-5 antagonist
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2256312A1 Prion protein binding proteins and uses thereof

1 ... 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 ... 3163